Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
超越数字：4位分析师讨论Gritstone Bio股票
In the latest quarter, 4 analysts provided ratings for Gritstone Bio (NASDAQ:GRTS), showcasing a mix of bullish and bearish perspectives.
在最近一个季度中，4位分析师为Gritstone Bio（纳斯达克股票代码：GRTS）提供了评级，显示了看涨和看跌的观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要概述了他们最近的评级，重点介绍了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $5.0, with a high estimate of $7.00 and a low estimate of $4.00. A decline of 9.09% from the prior average price target is evident in the current average.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为5.0美元，最高估计为7.00美元，低估值为4.00美元。目前的平均价格比先前的平均目标股价下降了9.09％。
Diving into Analyst Ratings: An In-Depth Exploration
深入分析师评级：深度探索
The standing of Gritstone Bio among financial...
通过对分析师近...
登录免费看全文
登录/注册